January 30, 2025

Tectonic Therapeutic (TECX) Stock Soars On Positive Clinical Trial Update

Leave a Comment / Featured, Mid Day Movers, US Stocks / By

The revelation of favorable interim data from a crucial clinical trial is causing Tectonic Therapeutics, Inc. (NASDAQ: TECX) shares soared 114.89% as of the last check to $55.27. Consequently, the market value of the firm has surpassed $800 million. To see more biotechnology businesses with market capitalizations over $1 billion, visit our ST screener link. …

Tectonic Therapeutic (TECX) Stock Soars On Positive Clinical Trial Update Read More »

Alterity (ATHE) Sees Major Stock Rally After Clinical Success

Leave a Comment / Mid Day Movers, US Stocks / By

Following the release of encouraging clinical trial data, Alterity Therapeutics Limited (NASDAQ: ATHE) stock value has significantly increased. ATHE shares have risen 47.42% to $4.29 as of the most recent market check. Alterity Unveiled Breakthrough in MSA Treatment The ATH434-201 Phase 2 clinical trial, a randomized, double-blind, placebo-controlled study evaluating ATH434 in individuals with early-stage …

Alterity (ATHE) Sees Major Stock Rally After Clinical Success Read More »

Calix (CALX) Sees Pre-Hour Trading Boost On Strong Results

Leave a Comment / Morning News, US Stocks / By

Calix, Inc. (NYSE: CALX) shares are trading 9.03% up at $40.20 as of the last check during today’s pre-market session. The increase comes after the release of its fourth-quarter earnings report, which showed continued revenue growth and operational efficiency. Strong Fourth-Quarter Performance Calix reported revenue of $206.1 million, up 2.6% from the previous quarter, marking …

Calix (CALX) Sees Pre-Hour Trading Boost On Strong Results Read More »

Pre-Market Boost For Celestica (CLS) As Investors React To Earnings Report

Leave a Comment / Morning News, US Stocks / By

As of the most recent check, Celestica Inc. (NYSE: CLS) share price jumped 13.28% to $113.84 during the pre-market session today. The surge followed the release of the company’s fourth-quarter earnings report, which highlighted exceptional financial success and great fiscal year 2024 results. Better Performance and Improved Outlook Celestica’s fourth-quarter revenues of $2.55 billion represented …

Pre-Market Boost For Celestica (CLS) As Investors React To Earnings Report Read More »

InflaRx (IFRX) Stock Sees After-Market Gains

Leave a Comment / Market News, US Stocks / By

After-hours trading on Wednesday saw InflaRx N.V. (NASDAQ: IFRX) shares rise 11.61%, finishing at $2.50. This spike, which comes before the firm takes part in a major industry event, indicates that investors are becoming more optimistic about the company’s prospects for the future. Moreover, IFRX has an ST score of 40 on our screener in …

InflaRx (IFRX) Stock Sees After-Market Gains Read More »

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

About

Categories

Social Links

Facebook Twitter Youtube Instagram Linkedin